Cargando…
Male patients with TERT mutation may be more likely to benefit from immunotherapy, especially for melanoma
Genomic mutation may be key factors for sex-biased disparities in cancer diagnosis, prognosis and prediction of treatment response. Current study has revealed that sex-based dimorphism on the efficacy of immune checkpoint inhibitors (ICIs) in various cancers and confirmed that male patients can bene...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521545/ https://www.ncbi.nlm.nih.gov/pubmed/32915164 http://dx.doi.org/10.18632/aging.103684 |